1. The cytokine response of human coronary artery endothelial cells treated with doxorubicin: results of an in vitro experiment.
- Author
-
Sinitskaya AV, Velikanova EA, Senokosova EA, Sinitsky MY, Khutornaya MV, Asanov MA, Poddubnyak AO, and Ponasenko AV
- Subjects
- Humans, Cells, Cultured, Interleukin-1beta metabolism, Interleukin-1beta pharmacology, Cytokines metabolism, Cytokines genetics, Gene Expression Regulation drug effects, Interleukin-8 metabolism, Interleukin-8 genetics, Chemokine CCL2 metabolism, Chemokine CCL2 genetics, Tumor Necrosis Factor-alpha metabolism, Tumor Necrosis Factor-alpha pharmacology, Interleukin-10 metabolism, Interleukin-10 genetics, Doxorubicin pharmacology, Coronary Vessels cytology, Coronary Vessels drug effects, Coronary Vessels metabolism, Endothelial Cells metabolism, Endothelial Cells drug effects, Interleukin-6 metabolism, Interleukin-6 genetics
- Abstract
The cytokine profile of primary coronary artery endothelial cells cultivated in the presence of doxorubicin (2 μg/ml and 6 μg/ml) was evaluated using enzyme-linked immunosorbent assay and qPCR. Cultivation of cells in the presence of these concentrations of doxorubicin for 24 h, upregulated expression of the following genes: IL6 (by 2.30 and 2.66 times, respectively), IL1B (by 1.25 and 3.44 times), and CXCL8 (by 6.47 times and 6.42 times), MIF (2.34 and 2.28 times), CCL2 (4.22 and 3.98 times). Under these conditions the following genes were downregulated: IL10, IL1R2, TNF. Cultivation of cells in the presence of doxorubicin (2 μg/ml and 6 μg/ml) for 24 h also increased the secretion of IL-6.
- Published
- 2024
- Full Text
- View/download PDF